Results 291 to 300 of about 572,169 (326)
Some of the next articles are maybe not open access.
Current pharmaceutical design, 2017
Cutaneous scars (particularly hypertrophic and keloid scars), not only can cause adverse cosmetic problems, but also can be associated with emotional distress such as anxiety and depression.
Qing-Qing Fang +8 more
semanticscholar +1 more source
Cutaneous scars (particularly hypertrophic and keloid scars), not only can cause adverse cosmetic problems, but also can be associated with emotional distress such as anxiety and depression.
Qing-Qing Fang +8 more
semanticscholar +1 more source
Ondansetron: A Novel Anti-anxiety Agent
1991Although the widely used benzodiazepines for control of anxiety have met with high patient acceptance, there is a hesitation about long-term use owing to the possibility of dependence. The new azaspirodecanedione compounds such as buspirone (Buspar) are free from dependence but raise the spectre of tardive dyskinesia since they are derivatives of the ...
openaire +2 more sources
ELECTROENCEPHALOGRAPHIC ASSAY OF ANTI-ANXIETY DRUGS.
Archives of General Psychiatry, 1964The determination of potency as well as of the peak and duration of action of drugs in man poses many problems, especially when dealing with agents which have prominent effects on the central nervous system.
C. Pfeiffer +3 more
semanticscholar +1 more source
Chapter 4. Anti-Anxiety Agents, Anticonvulsants, and Sedative-Hypnotics
1981Publisher Summary Rapid advances have been made in understanding the neurochemical mechanisms of benzodiazepines (BZs) and similar compounds responsible for their therapeutic actions. The “GABA hypothesis” relating to the actions of BZs in the brain continues to gain support.
Richard C. Effland, Manfred F. Försch
openaire +2 more sources
Chapter 3. Anti-Anxiety Agents, Anticonvulsants and Sedative-Hypnotics
1978Publisher Summary A specific benzodiazepine receptor has been found in rat and human brain cells that might mediate their pharmacological activities. Binding sites in the rat are unevenly distributed throughout the brain, and a loose parallel between the pharmacological potency and receptor affinity is found.
Gregory B. Bennett, William J. Houlihan
openaire +2 more sources
Chemotherapy in dental practice. Anti-anxiety agents. I. Meprobromate.
Dental digest, 1969 Ben Gurney
openalex +2 more sources
[Anti-emetic and anti-anxiety agents].
Perspective infirmiere : revue officielle de l'Ordre des infirmieres et infirmiers du Quebec, 2010 Jérôme Ouellet
openalex +2 more sources
Exploring the Therapeutic Potential of Terpenoids for Depression and Anxiety
Chemistry and BiodiversityThis review focus on the terpenoids as potential therapeutic agents for depression and anxiety disorders, which naturally found in a variety of plants and exhibit a wide range of biological activities.
Arif Azimi Md Noor
semanticscholar +1 more source
Chapter 2. Anti-Anxiety Agents, Anticonvulsants, and Sedative-Hypnotics
1982Publisher Summary This chapter discusses the biochemical mechanisms of action of anxiolytics, anticonvulsants and sedatives, and to a better understanding of the causes and nature of the disorders for which they are used. Strong evidence continues to support a functional link between benzodiazepines (BZ), gamma-aminobutyric acid (GABA), and chloride ...
openaire +2 more sources
Chemotherapy in dental practice anti-anxiety agents: 2. Diazepines.
Dental digest, 1969 Gurney Bf
openalex +2 more sources